Skip to main content

Angiogenesis Collection

Angiogenesis, the process of blood vessel formation, plays a crucial role in various pathological conditions

Background imageAngiogenesis Collection: Histopathology and pathophysiology of diabetic food ulcers

Histopathology and pathophysiology of diabetic food ulcers

Background imageAngiogenesis Collection: Digital illustration of angiogenesis process showing dormant tumour invading tissue, growing to mali

Digital illustration of angiogenesis process showing dormant tumour invading tissue, growing to mali

Background imageAngiogenesis Collection: Blood vessel formation, artwork C016 / 9842

Blood vessel formation, artwork C016 / 9842
Blood vessel formation. Artwork showing malignant (cancerous) tumour cells (green) promoting the formation of new blood vessels (pink), a process known as angiogenesis

Background imageAngiogenesis Collection: Tumour, computer artwork F007 / 0218

Tumour, computer artwork F007 / 0218
Tumour, computer artwork. Tumours are caused by the uncontrolled growth of previously normal cells. The resulting growth (green) can invade and damage surrounding tissue

Background imageAngiogenesis Collection: Tumour, computer artwork F007 / 0216

Tumour, computer artwork F007 / 0216
Tumour, computer artwork. Tumours are caused by the uncontrolled growth of previously normal cells. The resulting growth (blue) can invade and damage surrounding tissue

Background imageAngiogenesis Collection: Tumour, computer artwork F007 / 0214

Tumour, computer artwork F007 / 0214
Tumour, computer artwork. Tumours are caused by the uncontrolled growth of previously normal cells. The resulting growth (green) can invade and damage surrounding tissue

Background imageAngiogenesis Collection: Tumour, computer artwork F007 / 0212

Tumour, computer artwork F007 / 0212
Tumour, computer artwork. Tumours are caused by the uncontrolled growth of previously normal cells. The resulting growth (blue) can invade and damage surrounding tissue

Background imageAngiogenesis Collection: Regorafenib colorectal cancer drug F007 / 0187

Regorafenib colorectal cancer drug F007 / 0187
Regorafenib colorectal cancer drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red), chlorine (green)

Background imageAngiogenesis Collection: Regorafenib colorectal cancer drug F007 / 0186

Regorafenib colorectal cancer drug F007 / 0186
Regorafenib colorectal cancer drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red), chlorine (green)

Background imageAngiogenesis Collection: Pomalidomide cancer drug F007 / 0175

Pomalidomide cancer drug F007 / 0175
Pomalidomide cancer drug, molecular model. Pomalidomide is a derivative of the notorious drug thalidomide and inhibits angiogenesis, the formation of new blood vessels

Background imageAngiogenesis Collection: Pomalidomide cancer drug F007 / 0174

Pomalidomide cancer drug F007 / 0174
Pomalidomide cancer drug, molecular model. Pomalidomide is a derivative of the notorious drug thalidomide and inhibits angiogenesis, the formation of new blood vessels

Background imageAngiogenesis Collection: Pomalidomide cancer drug F007 / 0173

Pomalidomide cancer drug F007 / 0173
Pomalidomide cancer drug, molecular model. Pomalidomide is a derivative of the notorious drug thalidomide and inhibits angiogenesis, the formation of new blood vessels

Background imageAngiogenesis Collection: Integrin, molecular model F006 / 9388

Integrin, molecular model F006 / 9388
Integrin. Molecular model of the integrin protein alpha-v beta-3. This is a transmembrane protein that is found on platelets. It is composed of two subunits; integrin alpha-V and integrin beta 3

Background imageAngiogenesis Collection: Ribonuclease bound to angiogenin C015 / 5070

Ribonuclease bound to angiogenin C015 / 5070
Ribonuclease bound to angiogenin. Molecular model of a molecule of human angiogenin bound to a human placental ribonuclease inhibitor molecule

Background imageAngiogenesis Collection: Ribonuclease bound to angiogenin C015 / 5069

Ribonuclease bound to angiogenin C015 / 5069
Ribonuclease bound to angiogenin. Molecular model of a molecule of human angiogenin bound to a human placental ribonuclease inhibitor molecule

Background imageAngiogenesis Collection: Blood vessel formation, artwork

Blood vessel formation, artwork
Blood vessel formation. Artwork showing malignant (cancerous) tumour cells promoting the formation of new blood vessels, a process known as angiogenesis

Background imageAngiogenesis Collection: Integrin, molecular model C015 / 5441

Integrin, molecular model C015 / 5441
Integrin. Molecular model of the integrin protein alpha-v beta-3. This is a transmembrane protein that is found on platelets. It is composed of two subunits; integrin alpha-V and integrin beta 3

Background imageAngiogenesis Collection: Integrin, molecular model C015 / 5440

Integrin, molecular model C015 / 5440
Integrin. Molecular model of the integrin protein alpha-v beta-3. This is a transmembrane protein that is found on platelets. It is composed of two subunits; integrin alpha-V and integrin beta 3

Background imageAngiogenesis Collection: Angiogenesis inhibitors, conceptual image C013 / 7789

Angiogenesis inhibitors, conceptual image C013 / 7789
Angiogenesis inhibitors, conceptual image. Computer artwork showing a brick wall preventing new blood vessels from reaching a cancerous tumour

Background imageAngiogenesis Collection: Wound healing, artwork

Wound healing, artwork
Wound healing. Artwork 2 of 4 showing wound healing. This is the proliferative phase, which occurs between 2 to 5 days after the formation of the wound

Background imageAngiogenesis Collection: Fibroblast growth factor receptor 2

Fibroblast growth factor receptor 2 (FGFR2). Molecular models of the secondary structure (top) and the tertiary structure (bottom) of FGFR2



For sale as Licensed Images

Choose your image, Select your licence and Download the media

Angiogenesis, the process of blood vessel formation, plays a crucial role in various pathological conditions. In histopathology and the pathophysiology of diabetic foot ulcers, often impaired, leading to delayed wound healing and increased risk of infection. Through digital illustrations depicting the angiogenesis process, we can observe how dormant tumors invade surrounding tissues and grow into malignant masses. These visual representations provide valuable insights into the mechanisms behind tumor progression. Cross-sectional biomedical illustrations further shed light on how tumors obtain nutrients through angiogenesis. By developing an intricate network of blood vessels, tumors ensure their survival and growth by tapping into the body's resources. Artwork showcasing blood vessel formation emphasizes the importance in sustaining life processes. The intricate patterns formed by these vessels highlight their critical role in delivering oxygen and nutrients to different organs and tissues. Computer-generated images portraying tumors serve as powerful visuals that depict the destructive nature of cancer cells. These artworks aim to raise awareness about this devastating disease while highlighting its dependence on angiogenesis for sustenance. In addition to exploring tumor biology, medical illustrations also feature drugs like Regorafenib and Pomalidomide used in colorectal cancer treatment. These medications target specific pathways involved in tumor-induced angiogenesis, offering hope for patients fighting against this relentless disease. Overall, these captivating visuals not only showcase the complexity but also emphasize its significance in both normal physiological processes and pathological conditions such as cancer development. Understanding this intricate process opens doors for innovative therapeutic strategies aimed at inhibiting or promoting angiogenesis based on specific medical needs.